Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Stephen Padilla, 2 days ago
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.

Major depression: Getting a little help from zinc

01 Oct 2020

In patients with major depressive disorder (MDD) being treated with antidepressants, zinc supplementation contributes to a substantial reduction in depressive symptoms, a study has found.

The researchers searched multiple online databases for trials that assessed whether zinc supplementation could prevent depression in healthy individuals or reduce depressive symptoms in those with MDD. The initial search yielded 12,322 articles. Six studies were included in the review, and five of these were pooled for the meta-analysis.

Two studies were conducted in Poland, one in Guatemala, one in Japan, and one in Iran. Only one study involved children. Duration of supplementation ranged from 10 to 12 weeks, with doses varying between 7 mg and 25 mg, administered daily or weekly.

Compared with placebo, zinc supplementation produced a significant reduction in the Beck Depression Inventory score (standardized mean difference [SMD], –0.36, 95 percent confidence interval [CI], –0.67 to –0.04).

Results were consistent in the subgroup of individuals aged 40 years (SMD, –0.61, 95 percent CI, –1.12 to –0.09).

One way that zinc may reduce depression symptoms is by inhibition of the ionotropic glutamate receptor N-methyl-D-aspartate (NMDA), the activation of which facilitates increased glutamatergic neurotransmission, which is in turn associated with depression and neurotoxicity, according to the researchers. [Pol J Pharmacol 2001;53:641-645; Prog Neuropsychopharmacol Biol Psychiatry 2011;35:693-701]

Zinc aids in the function of brain and neural structures by modulating synaptic transmission and acting as an endogenous neuromodulator of important receptors such as NMDA and a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic (AMPA), and c-aminobutyric acid (GABA), they added. [Brain Res Rev 2009;62:33-44]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Stephen Padilla, 2 days ago
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.